Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The submucosal gland secretion machinery is a complex physiological system located primarily in the cartilaginous airways and parts of the gastrointestinal tract, responsible for producing the majority of mucus and antimicrobial fluids (Wine, J. J., 2007, J. Clin. Invest.). This machinery integrates the activity of various ion channels, such as the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Anoctamin-1 (TMEM16A), with transporters like the Na-K-2Cl cotransporter (NKCC1) to drive the osmotic movement of water into the gland lumen (Widdicombe, J. H., 2002, J. Anat.). These processes are regulated by autonomic signaling through M3 muscarinic and beta-2 adrenergic receptors, which trigger the exocytosis of MUC5B mucins and defensive proteins like lysozyme and lactoferrin (Fahy, J. V., & Dickey, B. F., 2010, N. Engl. J. Med.). In diseases like cystic fibrosis, the failure of the CFTR component leads to the secretion of hyperviscous mucus that impairs mucociliary clearance and promotes infection (Boucher, R. C., 2007, J. Biol. Chem.). Conversely, in COPD and asthma, hypertrophy of the glands and overactivity of the machinery result in mucus hypersecretion and airway obstruction. Pharmacological intervention typically targets individual components of this machinery, such as using CFTR modulators to restore hydration or muscarinic antagonists to reduce secretory volume.
Activation or inhibition of specific components within the machinery, such as ion channels (CFTR) or G protein-coupled receptors (M3 muscarinic), to modulate the volume and rheology of secreted mucus.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Submucosal gland secretion machinery.